Immediate Impact
9 standout
Citing Papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Multiple myeloma
2024 Standout
Works of Po‐Shen Ko being referenced
A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma
2020
Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Po‐Shen Ko | 76 | 70 | 64 | 37 | 230 | |
| Dominic Kaddu‐Mulindwa | 43 | 99 | 73 | 36 | 282 | |
| Juan Carlos Olivares‐Gazca | 71 | 38 | 87 | 47 | 230 | |
| Tatsuho Sugimoto | 39 | 46 | 65 | 26 | 287 | |
| Yasunobu Sekiguchi | 59 | 87 | 120 | 59 | 247 | |
| Atsuko Mugitani | 90 | 77 | 53 | 28 | 214 | |
| Hideyuki Kuwabara | 68 | 105 | 118 | 28 | 284 | |
| Parameswaran Anoop | 65 | 45 | 46 | 45 | 208 | |
| David Bosler | 39 | 52 | 72 | 30 | 251 | |
| Young Bae Choi | 90 | 63 | 23 | 35 | 294 | |
| Ayumi Numata | 141 | 94 | 76 | 37 | 295 |
All Works
Login with ORCID to disown or claim papers
Loading papers...